YAP1 and skin neoplasm: These data confirm that the anti-VEGFR3 peptide abolishes activation of the VEGF-C/VEGFR3-KRAS/MAPK signaling pathway to decrease the YAP1-mediated Slug expression, cancer stemness, migration and invasion of skin cancer cells.